Related Experiment Video
Updated: Jun 28, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
[Transplantation of patients with cardiovascular risk]
S Caillard1, O Inhoff, B Moulin
1Service de Néphrologie-Transplantation, Hôpitaux Universitaires de Strasbourg, 1, place de l'Hôpital 67091 Strasbourg, France. sophi.caillard@chru-strasbourg.fr
Insights
Kidney transplant patients with cardiovascular risk are increasing. Careful screening and tailored post-transplant care are crucial to manage cardiovascular mortality, the leading cause of death in these patients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Increasing prevalence of cardiovascular risk in patients undergoing hemodialysis.
- Hemodialysis patients represent a growing proportion of kidney transplant recipients.
- Cardiovascular disease remains the primary cause of mortality post-kidney transplantation.
Purpose of the Study:
- To highlight the growing trend of transplanting patients with cardiovascular risk.
- To emphasize the need for pre-transplant screening and post-transplant management strategies.
- To address the leading cause of death in kidney transplant recipients.
Main Methods:
- Review of current trends in hemodialysis patient characteristics.
- Analysis of patient survival data in kidney transplant recipients.
- Discussion of cardiovascular risk factors and management in the post-transplant phase.
Main Results:
- Patient survival post-transplantation has improved overall.
- Cardiovascular mortality persists as the leading cause of death.
- Systematic screening and adapted treatment are identified as necessary interventions.
Conclusions:
- Kidney transplantation in patients with cardiovascular risk is becoming more common.
- Proactive cardiovascular risk assessment and management are essential for improving outcomes.
- Tailored immunosuppressive therapy and cautious management of cardiovascular risk factors are recommended post-transplantation.
Abstract:
Transplantation of patients with cardiovascular risk is becoming more frequent because of the recent changes in the characteristics of hemodialysis patients. Improvement in patient survival after transplantation has been reported in the whole cohort and is probably applicable to cardiovascular risk patients. Nevertheless, cardiovascular mortality is the leading cause of death after transplantation. Systematic screening of patients before transplantation and adapted treatment after transplantation are needed. After transplantation, immunosuppressive treatment should be tailored to the patient's profile and cardiovascular risk factors should be managed cautiously.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure

